TETRAPHASE PHARMACEUTICALS INC 4
4 · TETRAPHASE PHARMACEUTICALS INC · Filed Mar 21, 2014
Insider Transaction Report
Form 4
Sutcliffe Joyce A.
Senior Vice President, Biology
Transactions
- Sale
Common Stock
2014-03-20$12.41/sh−11,494$142,641→ 17,242 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2013.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $12.17 to $12.59 per share. The reporting person hereby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price